Cargando…
How biomarker patterns can be utilized to identify individuals with a high disease burden: a bioinformatics approach towards predictive, preventive, and personalized (3P) medicine
Prevalences of non-communicable diseases such as depression and a range of somatic diseases are continuously increasing requiring simple and inexpensive ways to identify high-risk individuals to target with predictive and preventive approaches. Using k-mean cluster analytics, in study 1, we identifi...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648886/ https://www.ncbi.nlm.nih.gov/pubmed/34950251 http://dx.doi.org/10.1007/s13167-021-00255-0 |
_version_ | 1784610903136665600 |
---|---|
author | Bertele, Nina Karabatsiakis, Alexander Buss, Claudia Talmon, Anat |
author_facet | Bertele, Nina Karabatsiakis, Alexander Buss, Claudia Talmon, Anat |
author_sort | Bertele, Nina |
collection | PubMed |
description | Prevalences of non-communicable diseases such as depression and a range of somatic diseases are continuously increasing requiring simple and inexpensive ways to identify high-risk individuals to target with predictive and preventive approaches. Using k-mean cluster analytics, in study 1, we identified biochemical clusters (based on C-reactive protein, interleukin-6, fibrinogen, cortisol, and creatinine) and examined their link to diseases. Analyses were conducted in a US American sample (from the Midlife in the US study, N = 1234) and validated in a Japanese sample (from the Midlife in Japan study, N = 378). In study 2, we investigated the link of the biochemical clusters from study 1 to childhood maltreatment (CM). The three identified biochemical clusters included one cluster (with high inflammatory signaling and low cortisol and creatinine concentrations) indicating the highest disease burden. This high-risk cluster also reported the highest CM exposure. The current study demonstrates how biomarkers can be utilized to identify individuals with a high disease burden and thus, may help to target these high-risk individuals with tailored prevention/intervention, towards personalized medicine. Furthermore, our findings raise the question whether the found biochemical clusters have predictive character, as a tool to identify high-risk individuals enabling targeted prevention. The finding that CM was mostly prevalent in the high-risk cluster provides first hints that the clusters could indeed have predictive character and highlight CM as a central disease susceptibility factor and possibly as a leverage point for disease prevention/intervention. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s13167-021-00255-0. |
format | Online Article Text |
id | pubmed-8648886 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-86488862021-12-22 How biomarker patterns can be utilized to identify individuals with a high disease burden: a bioinformatics approach towards predictive, preventive, and personalized (3P) medicine Bertele, Nina Karabatsiakis, Alexander Buss, Claudia Talmon, Anat EPMA J Research Prevalences of non-communicable diseases such as depression and a range of somatic diseases are continuously increasing requiring simple and inexpensive ways to identify high-risk individuals to target with predictive and preventive approaches. Using k-mean cluster analytics, in study 1, we identified biochemical clusters (based on C-reactive protein, interleukin-6, fibrinogen, cortisol, and creatinine) and examined their link to diseases. Analyses were conducted in a US American sample (from the Midlife in the US study, N = 1234) and validated in a Japanese sample (from the Midlife in Japan study, N = 378). In study 2, we investigated the link of the biochemical clusters from study 1 to childhood maltreatment (CM). The three identified biochemical clusters included one cluster (with high inflammatory signaling and low cortisol and creatinine concentrations) indicating the highest disease burden. This high-risk cluster also reported the highest CM exposure. The current study demonstrates how biomarkers can be utilized to identify individuals with a high disease burden and thus, may help to target these high-risk individuals with tailored prevention/intervention, towards personalized medicine. Furthermore, our findings raise the question whether the found biochemical clusters have predictive character, as a tool to identify high-risk individuals enabling targeted prevention. The finding that CM was mostly prevalent in the high-risk cluster provides first hints that the clusters could indeed have predictive character and highlight CM as a central disease susceptibility factor and possibly as a leverage point for disease prevention/intervention. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s13167-021-00255-0. Springer International Publishing 2021-09-29 /pmc/articles/PMC8648886/ /pubmed/34950251 http://dx.doi.org/10.1007/s13167-021-00255-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Bertele, Nina Karabatsiakis, Alexander Buss, Claudia Talmon, Anat How biomarker patterns can be utilized to identify individuals with a high disease burden: a bioinformatics approach towards predictive, preventive, and personalized (3P) medicine |
title | How biomarker patterns can be utilized to identify individuals with a high disease burden: a bioinformatics approach towards predictive, preventive, and personalized (3P) medicine |
title_full | How biomarker patterns can be utilized to identify individuals with a high disease burden: a bioinformatics approach towards predictive, preventive, and personalized (3P) medicine |
title_fullStr | How biomarker patterns can be utilized to identify individuals with a high disease burden: a bioinformatics approach towards predictive, preventive, and personalized (3P) medicine |
title_full_unstemmed | How biomarker patterns can be utilized to identify individuals with a high disease burden: a bioinformatics approach towards predictive, preventive, and personalized (3P) medicine |
title_short | How biomarker patterns can be utilized to identify individuals with a high disease burden: a bioinformatics approach towards predictive, preventive, and personalized (3P) medicine |
title_sort | how biomarker patterns can be utilized to identify individuals with a high disease burden: a bioinformatics approach towards predictive, preventive, and personalized (3p) medicine |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648886/ https://www.ncbi.nlm.nih.gov/pubmed/34950251 http://dx.doi.org/10.1007/s13167-021-00255-0 |
work_keys_str_mv | AT bertelenina howbiomarkerpatternscanbeutilizedtoidentifyindividualswithahighdiseaseburdenabioinformaticsapproachtowardspredictivepreventiveandpersonalized3pmedicine AT karabatsiakisalexander howbiomarkerpatternscanbeutilizedtoidentifyindividualswithahighdiseaseburdenabioinformaticsapproachtowardspredictivepreventiveandpersonalized3pmedicine AT bussclaudia howbiomarkerpatternscanbeutilizedtoidentifyindividualswithahighdiseaseburdenabioinformaticsapproachtowardspredictivepreventiveandpersonalized3pmedicine AT talmonanat howbiomarkerpatternscanbeutilizedtoidentifyindividualswithahighdiseaseburdenabioinformaticsapproachtowardspredictivepreventiveandpersonalized3pmedicine |